Clinical trial
Exploring the Influence of Elevated Indoor CO2 Levels on Allergic Skin Disorders
NCT06244524 is registered in ClinicalTrials.gov with Swiss Institute of Allergy and Asthma Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploring the Influence of Elevated Indoor CO2 Levels on Allergic Skin Disorders
- Lead sponsor
- Swiss Institute of Allergy and Asthma Research
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2024
- Completion date
- March 31, 2025
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
affects of elevated indoor co2